Cite
HARVARD Citation
Monami, M. et al. (2017). Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials. Diabetes, obesity & metabolism. 19 (9), pp. 1233-1241. [Online].